Prahlad R. Singh Ph.D.
Net Worth

Last updated:

What is Prahlad R. Singh Ph.D. net worth?

The estimated net worth of Dr. Prahlad R. Singh Ph.D. is at least $40,873,554 as of 21 Dec 2022. He has earned $1,993,554 from insider trading and has received compensation worth at least $38,880,000 in PerkinElmer, Inc..

What is the salary of Prahlad R. Singh Ph.D.?

Dr. Prahlad R. Singh Ph.D. salary is $4,860,000 per year as Chief Executive Officer, Pres & Director in PerkinElmer, Inc..

How old is Prahlad R. Singh Ph.D.?

Dr. Prahlad R. Singh Ph.D. is 60 years old, born in 1965.

What stocks does Prahlad R. Singh Ph.D. currently own?

As insider, Dr. Prahlad R. Singh Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
PerkinElmer, Inc. (PKI) Chief Executive Officer, Pres & Director 48,282 $0 $0

What does PerkinElmer, Inc. do?

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Prahlad R. Singh Ph.D. insider trading

PerkinElmer, Inc.

Dr. Prahlad R. Singh Ph.D. has made 5 insider trades between 2017-2022, according to the Form 4 filled with the SEC. Most recently he sold 100 units of PKI stock worth $14,105 on 21 Dec 2022.

The largest trade he's ever made was exercising 14,187 units of PKI stock on 21 Dec 2022. As of 21 Dec 2022 he still owns at least 48,282 units of PKI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 100 $141.05 $14,105
Option
Common Stock 14,187 $48.98 $694,808
Option
NQ Stock Option (right to buy) 14,187 $48.98 $694,808
Sale
Common Stock 14,087 $140.52 $1,979,449
Option
Common Stock 10,636 $46.26 $491,968
Option
NQ Stock Option (right to buy) 10,636 $46.26 $491,968
Sale
Common Stock 10,636 N/A N/A
Option
Common Stock 3,289 N/A N/A
Sale
Common Stock 3,289 N/A N/A
Option
NQ Stock Option (right to buy) 3,289 N/A N/A
Sale
Common Stock 3,000 N/A N/A
Option
NQ Stock Option (right to buy) 6,576 N/A N/A
Option
Common Stock 6,576 N/A N/A

PerkinElmer key executives

PerkinElmer, Inc. executives and other stock owners filed with the SEC: